- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03602404
Estimating Usual Iodine Intake From Spot Urinary Iodine Concentrations (ITURN)
May 26, 2022 updated by: Maria Andersson, Swiss Federal Institute of Technology
Estimating the Usual Iodine Intake From Spot Urinary Iodine Concentrations to Obtain the Prevalence of Inadequate or Excess Iodine Intake in School-aged Children and Adults
The overall objective of this study is to develop a reliable method to obtain habitual iodine intakes from spot urinary iodine concentration (UIC) and to assess the prevalence of inadequate iodine intake in school-age children and women of reproductive age.
We will evaluate different methods to estimate iodine intake from UIC and estimate the prevalence of inadequate and excess iodine intake in UIC studies conducted in populations with low, adequate and high iodine intakes using the the established estimated average requirement (EAR)/Tolerable Upper Intake Level (UL) cut-point method.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
1592
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Morobe
-
Sia, Morobe, Papua New Guinea
- University of Papua New Guinea
-
-
-
-
-
Saint Petersburg, Russian Federation
- Almazov Medical Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
9 years to 13 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Apparently healthy school-age children and women of reproductive age
Description
Inclusion Criteria:
- lived in study area >= 12 months
- no reported intake of Amiodarone
- no history of thyroid dysfunction / goiter (past & present)
- no exposure to iodine containing contrast agents within the last 12 months
Second arm: Women aged 18 - 49, exclusion / inclusion criteria apply, plus non-pregnant, non-lactating.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Ecologic or Community
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
|---|
|
St. Petersburg: School aged children
Generally healthy 9 to 12 years old children
|
|
St. Petersburg: Women of reproductive age
Generally healthy non-pregnant, non-lactating women between 18 and 44 years of age
|
|
Papua New Guinea: School aged children
Generally healthy 9 to 12 years old children
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Estimated iodine intake
Time Frame: 17 months
|
Estimated daily iodine intake of the study population derived from urinary iodine and creatinine concentrations measured in spot urine samples
|
17 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Urinary iodine concentration
Time Frame: 17 months
|
Measured in spot urine samples and 24 h urine collections
|
17 months
|
|
Urinary creatinine concentration
Time Frame: 17 months
|
Measured in spot urine samples and 24 h urine collections
|
17 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2018
Primary Completion (Actual)
February 21, 2020
Study Completion (Actual)
February 21, 2020
Study Registration Dates
First Submitted
July 18, 2018
First Submitted That Met QC Criteria
July 18, 2018
First Posted (Actual)
July 26, 2018
Study Record Updates
Last Update Posted (Actual)
June 1, 2022
Last Update Submitted That Met QC Criteria
May 26, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- ITURN
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Iodine Deficiency
-
DTU National Food InstituteUniversity Hospital Bispebjerg and FrederiksbergRecruitingDiet Habit | Iodine Deficiency | Iodine ToxicityDenmark
-
Universidade do PortoHospital de Braga; NOVA Medical School; Centro Hospitalar De São João, E.P.E.; Centro... and other collaboratorsCompletedIodine Deficiency | Iodine Status in PregnancyPortugal
-
Mahidol UniversityCompleted
-
University of GlasgowCompleted
-
Swiss Federal Institute of TechnologyCompleted
-
Swiss Federal Institute of TechnologyUniversity of Zagreb; Global Alliance for Improved Nutrition; UNICEF; St. Luke's... and other collaboratorsCompletedIodine DeficiencyPhilippines, Switzerland, China, Croatia
-
EUthyroidUK Research and Innovation; EU HorizonRecruitingIodine DeficiencyBangladesh, Norway, Pakistan, Poland, United Kingdom
-
Swiss Federal Institute of TechnologyUNICEF; Pan American Health OrganizationCompletedIodine DeficiencyAntigua and Barbuda, Barbados, Belize, Dominica, Grenada, Jamaica, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago
-
Swiss Federal Institute of TechnologyCompletedIodine DeficiencyMorocco
-
qingya tangCompletedPregnancy | Iodine DeficiencyChina